BTG PLC Legal Ruling (2225R)
September 20 2017 - 1:00AM
UK Regulatory
TIDMBTG
RNS Number : 2225R
BTG PLC
20 September 2017
BTG plc: legal ruling
London, UK, 20 September 2017: BTG plc (LSE: BTG), the global
specialist healthcare company, announces that a Memorandum Opinion
has been issued by the Court of Chancery of Delaware ruling against
BTG in its previously announced litigation with Wellstat
Therapeutics Corporation concerning the commercialisation of
Vistogard(R) . The Court has found that BTG has breached the
distribution agreement and that Wellstat is entitled to damages of
$55.8m plus interest and costs.
BTG is surprised and disappointed by the Opinion and is
considering options, which include appealing the ruling and level
of damages awarded.
For further information contact
BTG
Andy Burrows, VP Corporate & Investor Relations
+44 (0)20 7575 1741; Mobile: +44 (0)7990 530 605
Stuart Hunt, Investor Relations Manager
+44 (0)20 7575 1582; Mobile: +44 (0)7815 778 536
Chris Sampson, Corporate Communications Director
+44 (0)20 7575 1595; Mobile: +44 (0)7773 251 178
FTI Consulting
Ben Atwell/Simon Conway
+44 (0)20 3727 1000
About BTG
BTG is a global specialist healthcare company bringing to market
innovative products in specialist areas of medicine to better serve
doctors and their patients. We have a portfolio of Interventional
Medicine products to advance the treatment of cancer, severe
emphysema, severe blood clots and varicose veins, and Specialty
Pharmaceuticals that help patients overexposed to certain
medications or toxins. Inspired by patient and physician needs, BTG
is investing to expand its portfolio to address some of today's
most complex healthcare challenges. To learn more about BTG, please
visit: btgplc.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEAENNFDFXEAF
(END) Dow Jones Newswires
September 20, 2017 02:00 ET (06:00 GMT)
Btg (LSE:BTG)
Historical Stock Chart
From Apr 2024 to May 2024
Btg (LSE:BTG)
Historical Stock Chart
From May 2023 to May 2024